Evidence map›Paper›PMID 24204128›Full record

ReviewClinical interventions in aging2013

Age-related reduction of cerebral ischemic preconditioning: myth or reality?

David Della-Morte, Francesco Cacciatore, Elisa Salsano, Gilda Pirozzi, Maria Teresa Del Genio, Iole D'Antonio, Gaetano Gargiulo, Raffaele Palmirotta, Fiorella Guadagni, Tatjana Rundek and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Clinical interventions in aging, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Ischemic Preconditioning of the Kidney.Bulletin of experimental biology and medicine · 2021
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Is age a key factor contributing to the disparity between success of neuroprotective strategies in young animals and limited success in elderly stroke patients? Focus on protein homeostasis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

David Della-MorteDepartment of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA ; Department of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele, Rome, Italy.
Francesco Cacciatore
Elisa Salsano
Gilda Pirozzi
Maria Teresa Del Genio
Iole D'Antonio
Gaetano Gargiulo
Raffaele Palmirotta
Fiorella Guadagni
Tatjana Rundek
Pasquale Abete
University of Naples Federico II · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo · ITFondazione Salvatore Maugeri · ITUniversity of Miami · USVita-Salute San Raffaele University · IT

Funding

Genetics Determinants of Extreme Phenotypes of Subclinical AtherosclerosisK24NS062737 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RUNDEK, TATJANA · 2009 to 2013
$975k
NINDS NIH HHS K24 NS 062737NINDS NIH HHS K24 NS062737
6 · The paper itself

Abstract

Stroke is one of the leading causes of death in industrialized countries for people older than 65 years of age. The reasons are still unclear. A reduction of endogenous mechanisms against ischemic insults has been proposed to explain this phenomenon. The "cerebral" ischemic preconditioning mechanism is characterized by a brief episode of ischemia that renders the brain more resistant against subsequent longer ischemic events. This ischemic tolerance has been shown in numerous experimental models of cerebral ischemia. This protective mechanism seems to be reduced with aging both in experimental and clinical studies. Alterations of mediators released and/or intracellular pathways may be responsible for age-related ischemic preconditioning reduction. Agents able to mimic the "cerebral" preconditioning effect may represent a new powerful tool for the treatment of acute ischemic stroke in the elderly. In this article, animal and human cerebral ischemic preconditioning, its age-related difference, and its potential therapeutical applications are discussed.

Indexed as

AgedAge FactorsAnimalsBrainBrain IschemiaHumansIschemic PreconditioningNeuroprotective AgentsNeuroprotective Agentselderlyischemic preconditioningmortalitystroketransient cerebral ischemic attack

Identifiers

PMID24204128
PMCPMC3817003
OpenAlexW1976458634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.